Tin ethyl etiopurpurin-induced photodynamic therapy for the treatment of human immunodeficiency virus-associated Kaposi's sarcoma

Current Therapeutic Research - Clinical and Experimental

Volumn 59, Issue 1, 1998, Pages 23-27

  Allison, Ron R ^a   Mang, Thomas S ^a   Wilson, Brummite D ^a   Vongtama, Vitune ^a  

^a BUFFALO GENERAL HOSPITAL   (United States)

Author keywords

Kaposi's sarcoma; Photodynamic therapy; Purlytin; SnET2

Indexed keywords

ETIOPURPURIN; PHOTOSENSITIZING AGENT; TIN ETHYL ETIOPURPURIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; KAPOSI SARCOMA; LASER; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

EID: 0031975549     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(98)85020-0     Document Type: Article

References (7)

1. Chah LY, Gill PS, Levine AM, et al. Radiation therapy for acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Clin Oncol. 1988;6:863-867.
2. Gill PS, Lunardi-Iskander Y, Louis S, et al. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. NEJM. 1996;335:1261-1269.
3. Evans LM, Itri LM, Campion M, et al. Interferon alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Immunother. 1991;10:39-50.
4. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoactivation of murine tumor. Cancer Res. 1976;36:2326-2329.
5. Wilson BD, Mang TS, Stoll H, et al. Photodynamic therapy in the treatment of basal cell carcinoma. Arch Dermatol. 1992;126:1597-1601.
6. Jones CM, Mang TS, Cooper M, et al. Photodynamic therapy in the treatment of Bowen's disease. J Am Acad Dermatol. 1992;27:979-982.
7. Wang CE, Schroeter AL, Su WPD. Acquired immunodeficiency syndrome-related Kaposi's sarcoma. Mayo Clin Proc. 1995;70:869-879.